Key result
Temporally controlled deletion of Rxrα in mononuclear phagocytes led to decreased phagocytic activity, reduced angiogenesis, and a greater myocardial defect 30 days after ischemia/reperfusion injury.
Why the study?
The impact of reduced Rxrα expression in mononuclear phagocytes on cardiac remodeling after myocardial infarction had not been investigated.
Reduction of Rxrα levels in monocytes and macrophages negatively impacts cardiac remodeling after myocardial infarction, suggesting RXRα as a potential therapeutic target.
RXRα supports post-MI repair in mice; hypothesis-generating for targeted modulation in patients.
Retinoid X receptors (RXRs), as members of the steroid/thyroid hormone superfamily of nuclear receptors, are crucial regulators of immune response during health and disease. RXR subtype expression is dependent on tissue and cell type, RXRα being the relevant isoform in monocytes and macrophages. Previous studies have assessed different functions of RXRs and positive implications of RXR agonists on outcomes after ischemic injuries have been described. However, the impact of a reduced Rxrα expression in mononuclear phagocytes on cardiac remodeling after myocardial infarction (MI) has not been investigated to date. Here, we use a temporally controlled deletion of Rxrα in monocytes and macrophages to determine its role in ischemia-reperfusion injury. We show that reduced expression of Rxrα in mononuclear phagocytes leads to a decreased phagocytic activity and an accumulation of apoptotic cells in the myocardium, reduces angiogenesis and cardiac macrophage proliferation in the infarct border zone/infarct area, and has an impact on monocyte/macrophage subset composition. These changes are associated with a greater myocardial defect 30 days after ischemia/reperfusion injury. Overall, the reduction of Rxrα levels in monocytes and macrophages negatively impacts cardiac remodeling after myocardial infarction. Thus, RXRα might represent a therapeutic target to regulate the immune response after MI in order to improve cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Räuber et al. (2022) studied Ischemia-reperfusion injury / myocardial infarction. Temporally controlled deletion of Rxrα in monocytes and macrophages was evaluated on Cardiac remodeling and myocardial defect after ischemia/reperfusion injury. Temporally controlled deletion of Rxrα in mononuclear phagocytes led to decreased phagocytic activity, reduced angiogenesis, and a greater myocardial defect 30 days after ischemia/reperfusion injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: